Spanish authors described a case of symptomatic hypoglycemia in T2DM hepatitis C patient at 18th day of sofosbuvir/ledipasvir treatment despite radical decrease of insulin dosage [35]. This evidence concerns the gene INS and hepatitis C virus infection.